Literature DB >> 8721266

Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field.

M Chatani1, Y Matayoski, N Masaki, T Teshima, T o Inoue.   

Abstract

PURPOSE: To investigate the effect of radiation field on the local control of early glottic carcinoma by prospective randomized study. PATIENTS AND METHODS: From May 1982 through February 1992, a total of 273 patients with early glottic carcinoma (T1N0M0) was treated at our department with a wedge filter technique using a shell to improve the dose distribution and immobilization during radiotherapy with 4 MV X-ray. Patients were randomly allocated to either treatment group A (radiation field size: 5 x 5 cm) or B (6 x 6 cm) using bilateral parallel opposed portals. Total radiation dose administered was 60 Gy in 30 fractions over a 6-week period.
RESULTS: The 5-year recurrence-free survival rates were 88% in groups A and B (no significant difference). Minor chronic complication such as persistent arytenoid edema lasting more than 6 months or benign polypoid lesion of vocal cord was more frequently observed in group B (23%) than in group A (17%) (p = 0.038) while acute mucosal reaction and skin reaction showed no significant differences.
CONCLUSION: A small field (5 x 5 cm) with an appropriate angle of wedge filter and shell fixing device is recommended to avoid adverse effect with keeping local control of early glottic carcinoma.

Entities:  

Mesh:

Year:  1996        PMID: 8721266

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  7 in total

1.  Outcome of radiotherapy in T1 glottic carcinoma: a population-based study.

Authors:  Elisabeth Victoria Sjögren; Ruud G J Wiggenraad; Saskia Le Cessie; Simone Snijder; Jaqueline Pomp; Robert Jan Baatenburg de Jong
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-07       Impact factor: 2.503

Review 2.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

3.  Radiation therapy for early glottic carcinoma (T1N0M0). The adverse effect of treatment interruption.

Authors:  M Chatani; Y Matayoshi; N Masaki; T Teshima; T Inoue
Journal:  Strahlenther Onkol       Date:  1997-10       Impact factor: 3.621

4.  Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.

Authors:  David I Rosenthal; Clifton D Fuller; Jerry L Barker; Bryan Mason; John A Garcia; Jan S Lewin; F Christopher Holsinger; C Richard Stasney; Steven J Frank; David L Schwartz; William H Morrison; Adam S Garden; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-11       Impact factor: 7.038

5.  Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial.

Authors:  Houda Bahig; David I Rosenthal; Félix-Phuc Nguyen-Tan; David C Fuller; Ying Yuan; Katherine A Hutcheson; Apostolos Christopoulos; Anthony C Nichols; Kevin Fung; Olivier Ballivy; Edith Filion; Sweet Ping Ng; Louise Lambert; Jennifer Dorth; Kenneth S Hu; David Palma
Journal:  BMC Cancer       Date:  2021-04-22       Impact factor: 4.430

6.  Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer.

Authors:  Chae-Seon Hong; Dongryul Oh; Sang Gyu Ju; Yong Chan Ahn; Jae Myoung Noh; Kwangzoo Chung; Jin Sung Kim; Tae-Suk Suh
Journal:  Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.679

Review 7.  Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.

Authors:  Hideya Yamazaki; Gen Suzuki; Satoaki Nakamura; Ken Yoshida; Koji Konishi; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.